Science Explorer Back to mapMap
Discussion

Elusys Therapeutics (United States)

Research works
19
▲ 68% vs 2018-21
Citations
263
13.7 per fractional work
Top-10% rate
9.4%
all institutions 10.0%
Open access
36%
world 40%
International
9%
world 18%

Not ranked overall: Elusys Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Elusys Therapeutics (United States) work in?

In all years, 49% of research at Elusys Therapeutics (United States) is in Health Sciences, 44% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (11%). It does 1.9× the world's share of Life Sciences.

Health Sciences: 9 fractional works · 49.3% of its workMedicine: 9 fractional works · 49.1% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 11.4% of its workNeurology: 1 fractional works · 6.9% of its workGenetics: 1 fractional works · 5.8% of its workOncology: 1 fractional works · 5.5% of its workPathology and Forensic Medicine: 1 fractional works · 4.0% of its workRheumatology: 1 fractional works · 4.0% of its workHematology: 1 fractional works · 3.1% of its workInfectious Diseases: 0 fractional works · 2.2% of its workPsychiatry and Mental health: 0 fractional works · 1.7% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workOphthalmology: 0 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.4% of its workSurgery: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.2% of its workLife Sciences: 8 fractional works · 44.1% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 27.6% of its workMolecular Biology: 2 fractional works · 9.4% of its workGenetics: 1 fractional works · 7.1% of its workBiotechnology: 1 fractional works · 4.9% of its workBiochemistry: 0 fractional works · 1.7% of its workPhysiology: 0 fractional works · 1.7% of its workEndocrinology: 0 fractional works · 1.5% of its workCell Biology: 0 fractional works · 0.9% of its workCancer Research: 0 fractional works · 0.4% of its workImmunology and Microbiology: 2 fractional works · 11.0% of its workImmunology: 2 fractional works · 9.7% of its workVirology: 0 fractional works · 1.3% of its workNeuroscience: 1 fractional works · 3.8% of its workCellular and Molecular Neuroscience: 1 fractional works · 3.8% of its workAgricultural and Biological Sciences: 0 fractional works · 1.7% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 1.1% of its workPlant Science: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 6.6% of its workChemistry: 1 fractional works · 3.5% of its workOrganic Chemistry: 0 fractional works · 1.7% of its workSpectroscopy: 0 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 2.2% of its workEcology: 0 fractional works · 2.0% of its workEcological Modeling: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.9% of its workBiomaterials: 0 fractional works · 0.9% of its workALL ITS WORKElusysTherapeutics…19fractional works, all years
Life Sciences44%Physical Sciences7%Health Sciences49%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Medicine949.1%
    2. Health Professions00.2%
    1. Biochemistry, Genetics and Molecular Biology527.6%
    2. Immunology and Microbiology211.0%
    3. Neuroscience13.8%
    4. Agricultural and Biological Sciences01.7%
    1. Chemistry13.5%
    2. Environmental Science02.2%
    3. Materials Science00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Elusys Therapeutics (United States)?

Ranked on the quality score, Leslie S. Casey lead among researchers whose main affiliation is Elusys Therapeutics (United States).

  1. 1 Leslie S. Casey United States · #2,598,657 worldwide 488 citations · 17 works
All ranked researchers at Elusys Therapeutics (United States)

What are the most cited papers from Elusys Therapeutics (United States)?

The most cited paper from Elusys Therapeutics (United States) is "A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge" (Nehal Mohamed, Michelle Clagett, Juan Li et al., 2005), with 124 citations. Next come "Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages" (62) and "Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax" (49).

Most cited papers
#PaperReleasedCitations
1 A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge Nehal Mohamed, Michelle Clagett, Juan Li et al. · Infection and Immunity Open access 20 Jan 2005 124
2 Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages Nehal Mohamed, Juan Li, Cláudia S. Ferreira et al. · Infection and Immunity Open access 20 May 2004 62
3 Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax Brent Yamamoto, Annette M. Shadiack, Sarah Carpenter et al. · Antimicrobial Agents and Chemotherapy Open access 19 Jul 2016 49
4 Inhaled vs subcutaneous effects of a dual IL‐4/IL‐13 antagonist in a monkey model of asthma Adrian Tomkinson, Jeffrey S. Tepper, Matthew T. Morton et al. · Allergy Oct 2009 46
5 Selective and efficient inhibition of the alternative pathway of complement by a mAb that recognizes C3b/iC3b David J. DiLillo, Andrew W. Pawluczkowycz, Peng Wu et al. · Molecular Immunology 15 Jun 2005 38
All 20 most cited papers, with filters and sorting

Which research topics does Elusys Therapeutics (United States) publish most on?

By volume in 2022-now: Autoimmune Neurological Disorders and Treatments, Genetics and Neurodevelopmental Disorders, Neuroscience and Neuropharmacology Research and Monoclonal and Polyclonal Antibodies Research.

  1. 1 Autoimmune Neurological Disorders and Treatments Neurology 1 works
  2. 2 Genetics and Neurodevelopmental Disorders Genetics 1 works
  3. 3 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Epilepsy research and treatment Psychiatry and Mental health 0 works
  6. 6 Amino Acid Enzymes and Metabolism Biochemistry 0 works
  7. 7 melanin and skin pigmentation Cell Biology 0 works
  8. 8 Immunotherapy and Immune Responses Immunology 0 works
  9. 9 Ocular Oncology and Treatments Ophthalmology 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.2%not open63.8%

World: 40% of research is openly available.

with international co-authors8.7%domestic only91.3%

World: 18% is written across borders.

How has Elusys Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 68% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Elusys Therapeutics (United States) as a percentage of every work published that year, 0.000018% in 2024.

still counting0.00010%0.00020%Elusys Therapeutics (United States)0.000030% in 202520102020

Fractional works of Elusys Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Morristown

All research institutions in Morristown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Elusys Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.